The aim of the present study was to evaluate the activity of the LHRH-agonist (Goserelin), in hormone-dependent breast cancer in dogs. The results showed that goserelin is effective in the treatment of hormone-dependent canine breast cancer, specifically acting on the hypothalamus-pituitary-ovary axis.

Goserelin is effective in the treatment of hormone-dependent canine mammary tumors

LOMBARDI, PIETRO;AVALLONE, LUIGI;TORTORA, GENNARO;D'ANGELO, DANILA;FLORIO, SALVATORE
1997

Abstract

The aim of the present study was to evaluate the activity of the LHRH-agonist (Goserelin), in hormone-dependent breast cancer in dogs. The results showed that goserelin is effective in the treatment of hormone-dependent canine breast cancer, specifically acting on the hypothalamus-pituitary-ovary axis.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11588/301732
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact